Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | progesterone receptor | Starlite/ChEMBL | References |
Homo sapiens | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 0.8 nM | Agonist activity at glucocorticoid receptor in human HepG2 cells co-transfected with GRE assessed as transactivation activity by luciferase reporter gene assay | ChEMBL. | 21115247 |
EC50 (functional) | = 483 nM | Agonist activity at glucocorticoid receptor in human HepG2 cells co-transfected with GRE assessed as transactivation activity by luciferase reporter gene assay | ChEMBL. | 21115247 |
Efficacy (binding) | = 40 % | Transrepression activity at glucocorticoid receptor in TNFalpha/IL1beta-stimulated human HepG2 cells assessed as inhibition of NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21115247 |
Efficacy (functional) | = 48 % | Agonist activity at glucocorticoid receptor in human HepG2 cells co-transfected with GRE assessed as transactivation activity by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21115247 |
Efficacy (binding) | = 56 % | Transrepression activity at glucocorticoid receptor in IL-1beta-stimulated human HepG2 cells assessed as inhibition of AP1 response element-induced IL-6 production by ELISA relative to Dexamethasone | ChEMBL. | 21115247 |
Efficacy (binding) | = 79 % | Transrepression activity at glucocorticoid receptor in TNFalpha/IL1beta-stimulated human HepG2 cells assessed as inhibition of NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21115247 |
Efficacy (binding) | = 103 % | Transrepression activity at glucocorticoid receptor in IL-1beta-stimulated human HepG2 cells assessed as inhibition of AP1 response element-induced IL-6 production by ELISA relative to Dexamethasone | ChEMBL. | 21115247 |
Efficacy (functional) | = 133 % | Agonist activity at glucocorticoid receptor in human HepG2 cells co-transfected with GRE assessed as transactivation activity by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21115247 |
IC50 (binding) | = 0.2 nM | Transrepression activity at glucocorticoid receptor in TNFalpha/IL1beta-stimulated human HepG2 cells assessed as inhibition of NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay | ChEMBL. | 21115247 |
IC50 (binding) | = 1.6 nM | Transrepression activity at glucocorticoid receptor in IL-1beta-stimulated human HepG2 cells assessed as inhibition of AP1 response element-induced IL-6 production by ELISA | ChEMBL. | 21115247 |
IC50 (binding) | = 100 nM | Transrepression activity at glucocorticoid receptor in IL-1beta-stimulated human HepG2 cells assessed as inhibition of AP1 response element-induced IL-6 production by ELISA | ChEMBL. | 21115247 |
Ki (binding) | = 0.9 nM | Displacement of radiolabeled Dexamethasone from glucocorticoid receptor expressed in baculovirus | ChEMBL. | 21115247 |
Ki (binding) | = 85 nM | Displacement of radiolabeled Dexamethasone from glucocorticoid receptor expressed in baculovirus | ChEMBL. | 21115247 |
Ki (binding) | = 1400 nM | Binding affinity to progesterone receptor | ChEMBL. | 21115247 |
Ki (binding) | = 2400 nM | Binding affinity to progesterone receptor | ChEMBL. | 21115247 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.